| CCCC |
C4 Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.9% |
$50.3M |
|
22.6M |
|
Point72 Asset Management, L.P. |
Oct 17, 2025 |
| CYBN |
CYBIN INC. |
Common Shares, no par value |
9.9% |
$37.8M |
$28.3M |
6.41M |
+299% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| PTNT |
PALATIN TECHNOLOGIES INC |
Common Stock, par value $0.01 per share |
9.9% |
$23.6M |
|
2.31M |
|
Point72 Asset Management, L.P. |
Nov 12, 2025 |
| FGNX |
FG Nexus Inc. |
Common Stock, par value $0.001 per share |
9.9% |
$22M |
$2.88M |
4M |
+15.1% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| IBIO |
iBio, Inc. |
Common Stock, par value $0.001 per share |
9.9% |
$9.72M |
|
14.3M |
|
Point72 Asset Management, L.P. |
Aug 22, 2025 |
| XLO |
Xilio Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.9% |
$6.74M |
$3.37M |
8M |
+100% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| IVVD |
Invivyd, Inc. |
Common Stock, par value $0.0001 per share |
9.7% |
$22.4M |
$4.01M |
20.4M |
+21.8% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| PRAX |
Praxis Precision Medicines, Inc. |
Common Stock, par value $0.0001 per share |
9.6% |
$110M |
$28.7M |
2.07M |
+35.4% |
Steven A. Cohen |
Sep 30, 2025 |
| APVO |
Aptevo Therapeutics Inc. |
Common Stock, par value $0.001 per share |
9.1% |
$510K |
|
300K |
|
Point72 Asset Management, L.P. |
Sep 16, 2025 |
| KRRO |
Korro Bio, Inc. |
Common Stock, par value $0.001 per share |
8.7% |
$10.7M |
|
817K |
|
Steven A. Cohen |
Jun 30, 2025 |
|
1RT Acquisition Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
8.7% |
|
|
1.5M |
|
Point72 Asset Management, L.P. |
Jul 3, 2025 |
| AVTX |
Avalo Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
8% |
$13.4M |
$5.91M |
1.05M |
+79.1% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| RLAY |
Relay Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
7.8% |
$50.2M |
$14M |
13.4M |
+38.7% |
Point72 Asset Management, L.P. |
Jun 30, 2025 |
| ANAB |
ANAPTYSBIO, INC |
Common Stock, par value $0.001 per share |
7.7% |
$49M |
$14M |
2.37M |
+40% |
Point72 Asset Management, L.P. |
Mar 31, 2025 |
| ZEPP |
Zepp Health Corp |
Class A Ordinary Shares, par value $0.0001 per share |
7.6% |
$402M |
$106M |
8.78M |
+35.6% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| TENX |
TENAX THERAPEUTICS, INC. |
Common Stock, par value $0.0001 per share |
7.4% |
$2.04M |
|
340K |
|
Point72 Asset Management, L.P. |
Oct 22, 2025 |
| ADCT |
ADC Therapeutics SA |
Common Shares, par value CHF 0.08 per share |
7% |
$21.7M |
|
7.83M |
|
Point72 Asset Management, L.P. |
Jun 16, 2025 |
| ANRO |
Alto Neuroscience, Inc. |
Common Stock, par value $0.0001 per share |
7% |
$4.35M |
-$1.03M |
1.91M |
-19.2% |
Steven A. Cohen |
Mar 31, 2025 |
| CLDX |
Celldex Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
6.7% |
$90.9M |
|
4.46M |
|
Point72 Asset Management, L.P. |
Jul 2, 2025 |
| PLRX |
PLIANT THERAPEUTICS, INC. |
Common Stock, par value $0.0001 per share |
6.7% |
$6.54M |
|
4.09M |
|
Point72 Asset Management, L.P. |
Aug 27, 2025 |
| GLTO |
Galecto, Inc. |
Common Stock, par value $0.00001 per share |
6.3% |
$372K |
|
100K |
|
Point72 Asset Management, L.P. |
Nov 12, 2025 |
| CDTX |
Cidara Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.2% |
$151M |
$4.8M |
1.58M |
+3.28% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| WWW |
WOLVERINE WORLD WIDE INC /DE/ |
Common Stock, par value $1 per share |
6.2% |
$139M |
$27.5M |
5.08M |
+24.6% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| ANGO |
ANGIODYNAMICS INC |
Common Stock, par value $0.01 per share |
6.2% |
$28.6M |
$4.91M |
2.56M |
+20.7% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| PALI |
PALISADE BIO, INC. |
Common Stock, par value $0.01 per share |
6.2% |
$4.4M |
|
7.59M |
|
Point72 Asset Management, L.P. |
Oct 6, 2025 |
| VSTM |
Verastem, Inc. |
Common Stock, par value $0.0001 per share |
6.1% |
$13.8M |
|
3.34M |
|
Point72 Asset Management, L.P. |
Jul 25, 2025 |
| CFLT |
Confluent, Inc. |
Class A Common Stock, par value $0.00001 per share |
6% |
$347M |
$60.8M |
17.5M |
+21.2% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
|
WOLFSPEED, INC. |
Common Stock, par value $0.00125 per share |
6% |
|
|
1.55M |
|
Steven A. Cohen |
Oct 9, 2025 |
| IMNM |
Immunome Inc. |
Common Stock, par value $0.0001 per share |
5.9% |
$41.6M |
|
4.89M |
|
Point72 Asset Management, L.P. |
Jan 31, 2025 |
| PAGS |
PagSeguro Digital Ltd. |
Class A Common Shares, par value $0.000025 per share |
5.7% |
$101M |
-$23M |
10.1M |
-18.5% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| MSGE |
Madison Square Garden Entertainment Corp. |
Class A Common Stock, par value $0.01 per share |
5.5% |
$72.8M |
|
2.24M |
|
Point72 Asset Management, L.P. |
Dec 31, 2024 |
| KOD |
Kodiak Sciences Inc. |
Common Stock, par value $0.0001 per share |
5.5% |
$21.2M |
|
2.91M |
|
Point72 Asset Management, L.P. |
Aug 15, 2025 |
| BRCB |
Black Rock Coffee Bar, Inc. |
Class A Common Stock, par value $0.00001 per share |
5.4% |
$22.6M |
|
948K |
|
Steven A. Cohen |
Nov 12, 2025 |
| DNTH |
Dianthus Therapeutics, Inc. /DE/ |
Common Stock, par value $0.001 per share |
5.3% |
$44.2M |
$14.1M |
2.12M |
+46.7% |
Point72 Asset Management, L.P. |
Sep 11, 2025 |
| DSGN |
Design Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
5.2% |
$11.9M |
|
2.94M |
|
Point72 Asset Management, L.P. |
Aug 27, 2025 |
| LION |
Lionsgate Studios Corp. |
Common Shares, no par value per share |
5.1% |
$101M |
|
14.7M |
|
Point72 Asset Management, L.P. |
Oct 31, 2025 |
| ORIC |
Oric Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
5.1% |
$23.4M |
|
4.4M |
|
Point72 Asset Management, L.P. |
May 29, 2025 |
| BILL |
BILL Holdings, Inc. |
Common Stock, par value $0.00001 per share |
5% |
$247M |
|
5.04M |
|
Point72 Asset Management, L.P. |
Nov 21, 2025 |
| IDYA |
IDEAYA Biosciences, Inc. |
Common Stock, par value $0.0001 per share |
5% |
$80.2M |
|
4.41M |
|
Point72 Asset Management, L.P. |
Jun 6, 2025 |
| RUN |
Sunrun Inc. |
Common Stock, par value $0.0001 per share |
5% |
$78.8M |
|
11.5M |
|
Point72 Asset Management, L.P. |
Jun 26, 2025 |
| SNDX |
Syndax Pharmaceuticals Inc |
Common Stock, par value $0.0001 per share |
5% |
$44.6M |
$20.8M |
4.33M |
+87.5% |
Point72 Asset Management, L.P. |
Aug 15, 2025 |
| LENZ |
LENZ Therapeutics, Inc. |
Common Stock, par value $0.00001 per share |
4.8% |
$63.2M |
|
1.36M |
|
Steven A. Cohen |
Sep 30, 2025 |
| REPL |
Replimune Group, Inc. |
Common Stock, par value $0.001 per share |
4.7% |
$15.2M |
-$3.49M |
3.63M |
-18.7% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| LLYVA |
Liberty Media Corp |
Series A Liberty Live Common Stock, par value $0.01 per share |
4.6% |
$77.3M |
|
1.16M |
|
Point72 Asset Management, L.P. |
Dec 31, 2024 |
| VTYX |
Ventyx Biosciences, Inc. |
Common Stock, par value $0.0001 per share |
4.5% |
$9.98M |
-$8.35M |
3.21M |
-45.6% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| RCUS |
Arcus Biosciences, Inc. |
Common Stock, par value $0.0001 per share |
4.1% |
$58.9M |
-$20.4M |
4.33M |
-25.7% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| COGT |
Cogent Biosciences, Inc. |
Common Stock, par value $0.001 per share |
4% |
$82.6M |
-$60.8M |
5.75M |
-42.4% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| ALTS |
ALT5 Sigma Corp |
Common Stock, par value $0.001 per share |
4% |
|
|
4.87M |
|
Point72 Asset Management, L.P. |
Aug 11, 2025 |
| STNE |
StoneCo Ltd. |
Class A Common Shares, par value US$0.000079365 per share |
3.9% |
$154M |
-$64M |
9.97M |
-29.3% |
Point72 Asset Management, L.P. |
Jun 30, 2025 |
| BCYC |
BICYCLE THERAPEUTICS PLC |
Ordinary Shares, nominal value 0.01 GBP per share |
3.9% |
$14.9M |
-$15M |
1.86M |
-50.2% |
Point72 Asset Management, L.P. |
Jun 30, 2025 |
| TDOC |
Teladoc Health, Inc. |
Common Stock, par value $0.001 per share |
3.3% |
$44.8M |
-$23.4M |
5.8M |
-34.3% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| ATYR |
aTYR PHARMA INC |
Common Stock, par value $0.001 per share |
3.2% |
$9.62M |
|
2.85M |
|
Point72 Asset Management, L.P. |
Mar 31, 2025 |
| PEPG |
PepGen Inc. |
Common Stock, par value $0.0001 per share |
3% |
$9.55M |
-$2.81M |
2.07M |
-22.7% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| DRUG |
BRIGHT MINDS BIOSCIENCES INC. |
Common Shares, without par value |
3% |
$4.18M |
|
135K |
|
Point72 Asset Management, L.P. |
Dec 31, 2024 |
| MBLY |
Mobileye Global Inc. |
Class A Common Stock, par value $0.01 per share |
2.8% |
$84.8M |
-$3.37M |
6.01M |
-3.82% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| TSEM |
TOWER SEMICONDUCTOR LTD |
Ordinary Shares, par value NIS 15.00 per share |
2.6% |
$206M |
-$252M |
2.85M |
-55% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| AMLX |
Amylyx Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
2.6% |
$38.1M |
-$26M |
2.8M |
-40.6% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| ENTX |
Entera Bio Ltd. |
Ordinary shares, par value NIS 0.0000769 per share |
2.6% |
$2.27M |
-$2.92M |
1.18M |
-56.2% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| CTMX |
CytomX Therapeutics, Inc. |
Common Stock, par value $0.00001 per share |
2.5% |
$13M |
-$12.8M |
4.07M |
-49.7% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| VNET |
VNET Group, Inc. |
Class A Ordinary Shares, par value $0.00001 per share |
2.4% |
$304M |
-$323M |
38.2M |
-51.6% |
Steven A. Cohen |
Jun 30, 2025 |
| RPD |
Rapid7, Inc. |
Common Stock, par value $0.01 per share |
2.4% |
$36.5M |
|
1.5M |
|
Point72 Asset Management, L.P. |
Dec 31, 2024 |
| OLMA |
Olema Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
2.3% |
$7.78M |
|
1.54M |
|
Point72 Asset Management, L.P. |
Mar 31, 2025 |
| ARRY |
Array Technologies, Inc. |
Common Stock, par value $0.001 per share |
2% |
$16.2M |
-$24.1M |
3.05M |
-59.9% |
Point72 Asset Management, L.P. |
Mar 31, 2025 |
| DYN |
Dyne Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
1.5% |
$18.5M |
-$39.2M |
1.67M |
-67.9% |
Point72 Asset Management, L.P. |
Mar 31, 2025 |
| LITE |
Lumentum Holdings Inc. |
Common Stock, par value $0.001 per share |
1.3% |
$83.3M |
-$308M |
895K |
-78.7% |
Point72 Asset Management, L.P. |
Jun 30, 2025 |
| SPHR |
Sphere Entertainment Co. |
Class A Common Stock, par value $0.01 per share |
0.8% |
$13.9M |
-$81.5M |
223K |
-85.4% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| RGLS |
Regulus Therapeutics Inc. |
Common Stock, par value $0.001 per share |
0.3% |
$1.98M |
-$30.2M |
241K |
-93.9% |
Point72 Asset Management, L.P. |
Jun 30, 2025 |
| ANNX |
Annexon, Inc. |
Common Stock, par value $0.001 per share |
0.1% |
$181K |
|
95.4K |
|
Point72 Asset Management, L.P. |
Mar 31, 2025 |
| WHWK |
Whitehawk Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
0% |
$7.83K |
-$2.26M |
5.09K |
-99.7% |
Point72 Asset Management, L.P. |
Mar 31, 2025 |
| KALA |
KALA BIO, Inc. |
Common Stock, par value $0.001 per share |
0% |
$393 |
-$717K |
257 |
-99.9% |
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| SYRS |
Syros Pharmaceuticals, Inc. |
Common Stock, par value $0.001 per share |
0% |
$14.90 |
|
496 |
|
Point72 Asset Management, L.P. |
Dec 31, 2024 |
| SGMT |
Sagimet Biosciences Inc. |
Series A Common Stock, par value $0.0001 per share |
0% |
$0 |
-$16.6M |
0 |
-100% |
Point72 Asset Management, L.P. |
Jun 30, 2025 |
| IKT |
Inhibikase Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
Point72 Asset Management, L.P. |
Dec 31, 2024 |
| SHLS |
Shoals Technologies Group, Inc. |
Class A Common Stock, par value $0.00001 per share |
0% |
$0 |
-$52.2M |
0 |
-100% |
Point72 Asset Management, L.P. |
Jun 30, 2025 |
| TSBX |
Turnstone Biologics Corp. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
Point72 Asset Management, L.P. |
Sep 30, 2025 |
| CDMO |
Avid Bioservices, Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
Point72 Asset Management, L.P. |
Dec 31, 2024 |
| JOYY |
JOYY Inc. |
Class A Common Shares, par value US$0.00001 per share |
0% |
$0 |
|
0 |
|
Point72 Asset Management, L.P. |
Mar 31, 2025 |